Related Experiment Videos
Detection of glomerular-binding immune elements in murine lupus using a tissue-based ELISA
K Bernstein1, D Bolshoun, G Gilkeson
1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
Clinical and Experimental Immunology
|March 1, 1993
Summary
Researchers developed a novel ELISA assay to detect glomerular binding activity (GBA) in lupus nephritis. This assay identified specific binding elements in mice with lupus, potentially aiding in understanding and diagnosing kidney disease in systemic lupus erythematosus (SLE).
Area of Science:
- Immunology
- Nephrology
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) induced glomerulonephritis is linked to immune element binding in glomeruli, but their nature remains unclear.
- Understanding these binding elements is crucial for elucidating lupus nephritis pathogenesis.
Purpose of the Study:
- To develop and validate a novel Enzyme-Linked Immunosorbent Assay (ELISA) for detecting and characterizing glomerular binding activity (GBA).
- To investigate the role of GBA in the pathogenesis of lupus nephritis.
Main Methods:
- Developed an ELISA utilizing intact glomeruli as the substrate to detect GBA in mouse serum.
- Analyzed GBA composition (IgG subclasses, IgM, IgA, C3) and its interaction with DNA.
- Fractionated serum components and assessed ex vivo and in vivo glomerular binding.
Main Results:
- Detected significant GBA in lupus-prone mice (MRL lpr, NZB x W, B x SB) but not in non-autoimmune mice.
- GBA in MRL lpr mice primarily contained IgG subclasses (1, 2a, 2b) and was sensitive to DNAase treatment, suggesting DNA involvement.
- GBA demonstrated tissue-specific binding to glomeruli and correlated with the presence of renal disease.
Conclusions:
- The novel ELISA assay successfully detected a heterogeneous glomerular binding activity (GBA) in lupus models.
- GBA appears to be involved in the pathogenesis of lupus nephritis and may serve as a potential disease marker.
- This assay provides a new tool for understanding the mechanisms underlying SLE-related kidney disease.